Nektar Therapeutics
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $1.72B | $194.9M |
| FY2019 | — | $1.41B | $96.4M |
| FY2020 | — | $1.08B | $199.0M |
| FY2021 | — | $679.5M | $25.2M |
| FY2022 | — | $366.6M | $88.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $1.72B | $194.9M |
| FY2019 | — | $1.41B | $96.4M |
| FY2020 | — | $1.08B | $199.0M |
| FY2021 | — | $679.5M | $25.2M |
| FY2022 | — | $366.6M | $88.2M |